$Histogenics(OCGN)$covaxin received 78% efficacy data FDA master file sent. Waiting for fda approval and rocket to the moon https://www.google.com/amp/s/www.moneycontrol.com/news/business/companies/bharat-biotech-covaxin-demonstrates-78-efficacy-in-phase-3-interim-analysis-6797601.html/amp